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a b s t r a c t
The filamentous fungus Mortierella alpina 1S-4 is capable of accumulating a large amount of triacylglyc-
erol containing C20 polyunsaturated fatty acids (PUFAs). Indeed, triacylglycerol production by M. alpina
1S-4 can reach 20 g/L of culture broth, and the critical cellular signaling and structural PUFA arachidonic
acid (ARA) comprises 30%–70% of the total fatty acid. The demonstrated health benefits of functional
PUFAs have in turn encouraged the search for rich sources of these compounds, including fungal strains
showing enhanced production of specific PUFAs. Screening for mutants and targeted gene manipulation
of M. alpina 1S-4 have elucidated the functions of various enzymes involved in PUFA biosynthesis and
established lines with improved PUFA productivity. In some cases, these strains have been used for
indistrial-scale production of PUFAs, including ARA. In this review, we described practical ARA production
through mutant breeding, functional analyses of genes encoding enzymes involved in PUFA biosynthesis,
and recent advances in the production of specific PUFAs through molecular breeding of M. alpina 1S-4.
 2018 Production and hosting by Elsevier B.V. on behalf of Cairo University. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Introduction
Fatty acids containing more than one carbon double bond, ter-
med polyunsaturated fatty acids (PUFAs), are critical sources of
metabolic energy, major structural components of membrane
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phospholipids, and precursors of the eicosanoid signaling mole-
cules prostaglandins, thromboxanes, and leukotrienes. Fish oils,
animal fats, and algal cells are among the most readily available
lipid sources rich in 20-carbon (C20) PUFAs. Among PUFAs, ARA
(ARA, C20:4n-6) is the most abundant C20 PUFA in humans, espe-
cially in the brain, muscles, and liver. ARA has multiple physiolog-
ical functions and is an important nutrient for infants and the
elderly [1,2]. ARA-derived lipid mediators can play various roles
in establishing homeostasis for the humans [3]. However, most
of the ARA in the humans is usually taken from dietary animal
sources such as meat and eggs [4], and the PUFA contents of these
conventional sources are insufficient for practical large-scale pro-
duction. Alternatively, c-linolenic acid (GLA, 18:3n-6)-containing
oils have been produced using Mucor fungi as the first attempt at
microbial PUFA production [5,6]. Mortierella fungi, such as M.
alpina ATCC32222 [7], were found as ARA producer and have been
used as commercial ARA producers. Recently, the various innova-
tions on metabolic engineering using gene engineering and meta-
bolomics for PUFA production by Mortierella fungi have reported,
e.g. overexpression of malic enzyme increased the fatty acid con-
tent in M. alpina ATCC32222 [8–11].
The oil-producing filamentous fungus M. alpina 1S-4 is also a
promising source of PUFAs such as ARA. M. alpina 1S-4 is the first
strain found as the high ARA producer and can accumulate various
PUFAs through the n-6 PUFA biosynthetic pathway as well as
eicosapentaenoic acid (EPA, 20:5n-3) through the n-3 PUFA biosyn-
thetic pathway [12–14]. InM. alpina 1S-4, most PUFAs are stored in
lipid droplets as triacylglycerols, while some are present in the
form of phospholipids as structural components of membranes.
Given the high ARA content of M. alpina 1S-4, this fungus is one
of the fungal models for both fundamental and applicative studies
on fatty acid biosynthesis, including the development of strains
suitable for large-scale production of specific PUFAs. In fact, ARA,
dihomo-c-linolenic acid (DGLA, 20:3n-6), and Mead acid (MA,
20:3n-9) have been commercially produced by Mortierella fungi
[15–19].
Although such successes over the last 30 years have generated
much interest in the development of microbial fermentation pro-
cesses for the large-scale production of specific PUFAs, improved
yields require more efficient biotechnological strategies for meta-
bolic engineering of microorganism lipogenesis. This article
reviews recent advances in the breeding of commercially viable
PUFA-producing M. alpina strains by conventional chemical muta-
genesis, the development of gene manipulation systems for M.
alpina 1S-4, and the latest molecular breeding strategies for pro-
ducing rare fatty acids using molecular genetics.
ARA-producing Mortierella sp.
Since the first reports of Mortierella strains producing ARA in
1987 [14,20], this genus has been studied extensively as a promis-
ing single-cell oil (SCO) source for various types of PUFAs [21,22].
In particular, M. alpina 1S-4 has been studied for fundamental
and applicative purposes, and has been used successfully for the
commercial production of ARA-enriched SCO (Table 1)
[7,13,14,23–29]. Mortierella alpina 1S-4 has the unique capacity
to synthesize a wide range of PUFAs (Fig. 1), and has several
additional advantages as both a model organism for studies on fun-
gal lipid metabolism and an industrial lipid producer demonstrat-
ing particularly high yields of multiple PUFAs under energetically
favorable culture conditions.
The total lipid fraction of M. alpina 1S-4 contains n-9, n-6, and
n-3 PUFAs. The predominant PUFA, ARA, is synthesized from 16:0
by four desaturases and two elongases. Under culture conditions
optimal for large-scale production, the total amount of lipid can
reach 500–600 mg/g dry cell weight or 20 g/L of culture broth.
Moreover, the ARA composition ranges from 30% to 70% of the total
cellular fatty acid (70%–90% of which is present in triacylglycerols)
[25,30,31]. This strain also produces EPA (approximately 10% of
total fatty acids) with cultivation below 20 C and exhibits higher
EPA production upon the addition of a-linolenic acid (18:3n-3)-
containing oils, such as linseed oil, to the medium [32].
Enzymes involved in ARA biosynthesis in M. alpina 1S-4
Arachidonic acid biosynthesis requires the activity of several
fatty acid desaturases and elongases. The primary substrate hex-
adecanoic acid (16:0) is converted to ARA in sequential steps cat-
alyzed by elongase 1 (MALCE1), D9 desaturase, D12 desaturase,
D6 desaturase, elongase 2 (GLELO), and D5 desaturase, respec-
tively (Fig. 1 and Table 2). Some of these enzymatic steps in M.
alpina 1S-4 contain a NADH-cytochrome b5 reductase and cyto-
chrome b5 as an electron transport system for fatty acid desatura-
tion [33–35]. Cytochrome b5 is a small hemoprotein which is an
integral component of the microsomal membranes and functions
as an electron carrier in a number of microsomal oxidation/reduc-
tion reactions, including fatty acid desaturation, cholesterol
biosynthesis and reduction of cytochrome P450.
The two D9 desaturase homologues (designated as D9-1 and
D9-2) in M. alpina 1S-4 have a cytochrome b5-like domain linked
to the carboxyl terminus, similar to yeast D9 desaturase [36].
TheM. alpina 1S-4 D9-1 exhibits 45% amino acid sequence similar-
ity with the yeast Saccharomyces cerevisiae homologue and 34%
with the rat homologue, suggesting that M. alpina D9-1 is a con-
served membrane-bound protein using acyl-CoA as substrate. Both
D9-1 and D9-2 desaturate 18:0 to oleic acid (18:1n-9). Although
the D9-2 gene is not transcribed in the wild-type, D9-2 protein
was expressed and exhibited D9 desaturation activity in a D9-1
gene-defective mutant [37]. TheM. alpina D12 andx3 desaturases,
both of which lack a cytochrome b5-like domain, have been charac-
terized by heterologous gene expression systems. The M. alpina
D12 desaturase was confirmed to catalyze the desaturation of
18:1n-9 to 18:2n-6 in both S. cerevisiae and Aspergillus oryzae
[38]. The M. alpina x3 desaturase shows 51% sequence identity
with M. alpina D12 desaturase. It converts n-6 PUFAs to n-3 PUFAs
with C18 and C20 chain lengths, and is particularly efficient at con-
verting ARA to EPA [39]. Furthermore, the M. alpina x3 desaturase
exhibits two additional activities when expressed in S. cerevisiae,
insertion of C@C double bonds at the D12-position and D15-
position of hexadecenoic acid (16:1n-7) [40].
TheM. alpina D5 and D6 desaturases have a cytochrome b5-like
domain linked to the N-terminus. A complementary DNA (cDNA)
encoding D5 desaturase has been isolated from two M. alpina
strains, CBS210.32 and ATCC32221 [41,42]. Mortierella alpina D5
desaturase inserts C@C double bond at the D5-position of PUFAs,
thereby converting DGLA into ARA. Two D6 desaturase homo-
logues (designated D6-1 and D6-2) are also present in M. alpina
Table 1
Arachidonic acid (ARA) production by various Mortierella strains.
Microorganism ARA productivity Scale Ref.
Mortierella alpina 1S-4 3.6 g/L/7 days 5 L fermentor [29]
3.0 g/L/10 days 2 kL fermentor [13]
13 g/L/10 days 10 kL fermentor [25]
M. alpina ATCC32221 11 g/L/16 days 500 L fermentor [28]
M. alpina ATCC32222 11 g/L/11 days 250 mL flask [7]
M. alpina DSA-12 18.8 g/L/12.5 days 12 L fermentor [26]
M. alpina ME-1 19.8 g/L/7 days 5 L fermentor [27]
Mortierella elongata 1S-5 1.0 g/L/4 days 500 mL flask [14]
Mortierella schmuckeri S12 2.3 g/L/3 days 14 L fermentor [24]
Mortierella alliacea YN-15 7.1 g/L/6 days 50 L fermentor [23]
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1S-4 [43,44]. Expression of the full-length cDNA clone in A. oryzae
resulted in greater accumulation of GLA, reaching 25.2% of the total
fatty acid content. The amino acid sequence homology between
D6-1 and D6-2 is very high (92%). Usually, D6-1 gene transcription
is 2-fold to 17-fold higher thanD6-2 gene transcription inM. alpina
1S-4. However, transcription of the D6-2 gene was enhanced up to
8-fold in D6-1 gene-silenced M. alpina 1S-4 compared to the wild-
type, suggesting that D6-2 may compensate when D6-1 activity is
deficient [45]. Two fatty acid elongases, MALCE1 and GLELO, are
also involved in the ARA biosynthetic pathway. GLELO is aD6 elon-
gase that catalyzes the elongation of both C18 n-3 and C18 n-6
PUFAs to the corresponding C20 PUFAs [46]. The M. alpina malce1
gene was confirmed to encode a fatty acid elongase that efficiently
catalyzed the elongation of 16:1n-7, 18:2n-6, and 18:3n-3 when
expressed in S. cerevisiae. Furthermore, MALCE1 also catalyzes
the elongation of 16:0 to 18:0 in M. alpina 1S-4. Indeed, this is its
primary activity in M. alpina 1S-4 [47].
Gene manipulation in M. alpina 1S-4
A transformation system for M. alpina 1S-4 has been developed
using M. alpina uracil auxotrophs as the host strain and a comple-
mentary gene as a selection marker [48]. Transformation with M.
alpina 1S-4 spores and a vector containing the M. alpina 1S-4 ura5
gene as a marker was achieved with high efficiency (transformant
frequency of 0.4/mg of vector DNA) usingmicroprojectile bombard-
ment [49,50]. Southern blot analysis revealed that most of the inte-
grated plasmids in stable transformants were present as multiple
copies at ribosomal DNA (rDNA) positions and/or at random posi-
tions in the chromosomal DNA. An Agrobacterium tumefaciens-
mediated transformation system for M. alpina 1S-4 has also been
developed [51] inwhich the ura5 gene is used as a selectablemarker
under control of the homologous histone H4.1 promoter in the
transfer-DNA region. The frequency of transformation reachedmore
than 400/108 spores using this system, and Southern blot analysis
revealed that most of the integrated transfer-DNAs appeared as a
single copy at random position in the chromosomal DNA.
Mortierella alpina 1S-4 exhibits resistance to various antibiotics
used to destroy other filamentous fungi. However, Zeocin- and
Carboxin-resistance markers have been developed for selection of
M. alpina 1S-4 [52,53]. A high concentration of Zeocin (20 mg/mL)
Table 2
Substrates and products of enzymes involved in arachidonic acid (ARA) biosynthesis
in M. alpina 1S-4.
Type Isozyme Substrate Product
D9 desaturase D9-1 18:0 18:1n-9
D9-2 18:0 18:1n-9
D12 desaturase – 18:1n-9 18:2n-6
D6 desaturase D6-1 18:2n-6 GLA
D6-2 18:2n-6 GLA
D5 desaturase – DGLA ARA
x3 desaturase – n-6 PUFA n-3 PUFA
16:1n-7 16:2n-4, 16:3n-1
MALCE1 – 16:0 18:0
GLELO – GLA DGLA
Cyt.b5 reductase Cyt.b5 reductase-1 – –
Cyt.b5 reductase-2 – –
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Fig. 1. Biosynthetic pathway of PUFAs inMortierella alpina 1S-4. ARA is biosynthesized through desaturation by D9, D12, D6, and D5 desaturases and elongation by MALCE1
and GLELO. The n-3, n-6, and n-9 PUFAs derived from 18:1n-9 (a), the n-1, n-4, and n-7 PUFAs derived from 16:1n-7 (b), and the non-methylene-interrupted PUFAs detected in
D6 desaturase-defective mutants (c). DX, DX desaturase; x3, x3 desaturase; EL, fatty acid elongase; ARA, arachidonic acid; DGLA, dihomo-c-linolenic acid; EPA,
eicosapentaenoic acid; ETA, x3 eicosatetraenoic acid; MA, Mead acid.
H. Kikukawa et al. / Journal of Advanced Research 11 (2018) 15–22 17
completely inhibited the germination of M. alpina 1S-4 spores, and
decreased the growth rate of fungal filaments. On the other hand,
the fungicide Carboxin (100 mg/mL) completely inhibitedM. alpina
1S-4 hyphal growth and spore germination. These genes for Zeocin
and Carboxin resistance have proven useful as selectivemarkers for
the transformation of both the parental strain and mutants.
To develop a more effective gene expression system for M.
alpina 1S-4, the transcriptional activity of each promoter was eval-
uated using the b-glucuronidase (GUS) reporter assay system [54].
The GUS gene was synthesized with optimized codon usage for M.
alpina and inserted into a basic vector under control of the histone
H4.1 promoter and SdhB gene terminator for reporter assays.
Approximately 30 promoter regions were replaced with the his-
tone H4.1 promoter and evaluated for expression activity. Seven
promoters with high-level constitutive or time-dependent expres-
sion were selected, and deletion analysis determined the promoter
regions required to retain the expression activities. Furthermore,
using an inducible GAL10 promoter, an approximately 50-fold
increase in GUS activity was achieved by addition of galactose to
the culture media at any cultivation phase [55].
The integration of exogenous DNA into chromosomes occurs
through two DNA double-strand break repair pathways, homolo-
gous recombination (HR) and non-homologous end joining (NHEJ)
[56]. In HR, exogenous DNA is integrated into the chromosome
using homologous regions as templates for precise gene insertion.
The HR method is used frequently for insertion of exogenous
expression constructs to disrupt target genes (gene targeting)
(Fig. 2A). However, these two pathways are independent of one
another and often function competitively [57]. Gene targeting sys-
tems have also been developed by disruption of key proteins
involved in NHEJ [58,59], such as Ku80 or DNA ligase IV (lig4).
We identified and disrupted the ku80 and lig4 genes in M. alpina
1S-4 to improve gene-targeting efficiency. These gene-disrupted
strains showed no defect in vegetative growth, spore formation,
or fatty acid production. Importantly, the efficiency of gene-
targeting through HR was improved only in the lig4-disrupted
strain, where it was 21-fold (67%) greater than that of the host
strain. Metabolic engineering using lig4 gene-disrupted strains as
hosts is expected to produce higher levels of rare and beneficial
PUFAs and contribute to basic research on fungal lipogenesis.
PUFA production by M. alpina 1S-4 mutants and transformants
Numerous desaturase-deficient and (or) elongase-deficient
mutants have been isolated by treating M. alpina 1S-4 spores with
the chemical mutagen N-methyl-N0-nitro-N-nitrosoguanidine
(Table 3) [60–65]. The M. alpina 1S-4 wild-type can accumulate
n-3 PUFAs only when cultivated at low temperature (below 20
C), while the x3 desaturase-defective mutants are unable to syn-
thesize n-3 PUFAs even when grown at low temperature [60,66].
The wild-type usually shows the highest ARA yield at 20 C,
although a portion of the accumulated ARA is further converted
to EPA, so the resultant oil includes a small amount of EPA
(ca. 3%). Therefore, these mutants (e.g., Y11 and Y61 strain) are
superior to the wild-type for production of SCO with a relatively
higher ARA content [64,66]. Additionally, rare fatty acids accumu-
lated in M. alpina 1S-4 by suppression of MALCE1-mediated 16:0
elongation to 18:0 or by supplementation of exogenous fatty acids
such as 16:1n-7 into the culture medium (Fig. 1b).
This practical transformation system for M. alpina 1S-4 allows
overexpression, RNA interference (RNAi), and disruption of genes
involved in PUFA biosynthesis for improved production of desired
PUFAs. Several valuable M. alpina mutants were directly trans-
formed with drug resistance markers, or their uracil auxotrophs
were transformed with the ura5 marker. Molecular breeding of
M. alpina 1S-4 and its mutants yielded unique fatty acid profiles
and high productivities of valuable PUFAs (Table 3 and 4). Mutant











Fig. 2. Gene-disruption through double crossing-over HR (A) and chromatograms
of fatty acid methyl esters prepared from a control strain (lig4 disruptant) and D5
desaturase gene-disrupted strain (B).
Table 3
Mutants described in the present review.
Mutant Deficient enzyme Product Productivity and characteristics Ref.
Y11 x3 desaturase ARA 1.5 g/L, 45% of total fatty acid with no n-3 PUFAs [64,66]
Y61 x3 desaturase ARA 1.8 g/L [66]
JT-180 D12 desaturase MA 2.6 g/L, 49% [65]
Enhanced activities of D5 and D6 desaturases
S14 D5 desaturase DGLA 4.1 g/L and low ARA content (<1%) [61]
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D6 desaturase activities, resulting in the efficient production of
Mead acid (MA, 20:3n-9) [65]. With overexpression of the endoge-
nous D12 desaturase gene, JT-180 accumulated a larger amount of
ARA (2.0 g/L/7 days, 39% of total fatty acids) but little MA com-
pared to the wild-type (1.2 g/L/7 days, 21%) due to enhanced D5
and D6 desaturation. Overexpression of the endogenous malce1
gene in M. alpina 1S-4 also led to faster and greater ARA accumu-
lation (0.76 g/L/6 days, 34%) than in the wild-type (0.68 g/L/6 days,
28%). In addition, overexpression of the gene encoding GLELO,
which has been suggested to catalyze the rate limiting step in
ARA biosynthesis [67], was successfully performed in M. alpina
1S-4 [68]. The resulting transformants yielded more ARA (3.6 g/L/
10 days, 28%) than the wild-type (1.9 g/L/10 days, 19%). Overex-
pression of both malce1 and glelo genes had substantial effects on
ARA production by M. alpina 1S-4. The exogenous D5 and D6
desaturases (PavD5, OstD6) from the microalgae Pavlova salina
and Ostreococcus lucimarinus and the D12 desaturase (TriD12)
from the beetle Tribolium castaneum have desaturation activities
for fatty acyl-CoA substrates. On the other hand, the homologous
desaturases from M. alpina use phospholipids as substrates. By
expressing these exogenous desaturases, higher ARA yields were
obtained (unpublished data) [69]. For instance, overexpression of
the PavD5 gene in the wild-type led to a markedly high ARA/DGLA
ratio, while overexpression of the OstD6 gene in the wild-type led
to higher 18:3n-6, DGLA, and ARA contents as proportions of total
fatty acid compared to the wild-type. Similarly, overexpression of
the TriD12 gene in the wild-type led to greater proportions of
18:2n-6, 18:3n-6, DGLA, and ARA compared to the wild-type.
The RNAi method using double-strand RNA has been applied to
silence gene expression in M. alpina 1S-4 [70]. By suppressing
endogenous D6-1 gene expression by RNAi in the mutant JT-180,
18:1n-9 accumulation reached 68.0% of total fatty acid content,
and 18:1n-9 production in broth reached 2.76 g/L [45].
Overexpression systems using promoters that exhibit high tran-
scriptional activities may facilitate further improvements in PUFA
production. Usually,M. alpina can express x3 desaturation activity
and accumulate n-3 PUFAs when cultured at low temperatures
(below 20 C), with an EPA ratio of approximately 10%, while no
accumulation of n-3 PUFAswas observed at 28 C. However, overex-
pression of the endogenousx3 desaturase gene inM. alpina 1S-4 at
20 C increased EPA accumulation to 40% of total fatty acid [51].
Expression of the heterologous Saprolegnia diclina D17 desaturase
(sdd17m) gene in the x3 desaturase-defective mutant ST1358
[71] resulted in EPA content as high as 26.4% of total fatty acid or
1.8 g/L at 28 C [72]. While wildM. alpina accumulates only a small
amount of the n-3 eicosatetraenoic acid (ETA, 20:4n-3) at low tem-
perature (below 20 C), this ETA was successfully produced by
molecular breeding [73]. Further, by overexpression of the heterol-
ogous sdd17m gene controlled by an SSA2 promoter showing high
transcriptional activity, ETA productivity in a D5 desaturase-
defective mutant S14 reached 24.9% of total fatty acid at 28 C [61].
Gene targeting may also be a valuable strategy for development
of M. alpina strains producing SCO containing rare PUFAs. DGLA-
producing transformants were constructed by disruption of the
D5 desaturase gene, which encodes a key enzyme catalyzing the
bioconversion of DGLA to ARA, in the lig4 gene-disrupted strain
of M. alpina 1S-4 [74]. The uracil auxotroph of the lig4 gene-
disrupted strain was transformed for disruption of the D5 desat-
urase gene through double crossing-over HR, and the targeting effi-
ciency was calculated as 50%. The ratio of DGLA to total fatty acid
in this disruptant reached 40.1%; however, no ARA was detected
(Fig. 2). Thus, DGLA oil can be produced without ARA contamina-
tion. Such disruptants are superior to defective mutants (e.g.,
M. alpina 1S-4 mutant S14 constructed by chemical mutagenesis)
for practical production of DGLA. Using the same methodology,
MA-producing disruptants were constructed by disruption of the
D12 desaturase gene (unpublished data) [75]. These disruptants
showed no defects in growth, spore germination, and fatty acid
production, but exhibited higher MA composition (8.4% of the total
fatty acid) than the MA-producing D12 desaturase-defective
mutant JT-180 (4.5%), with no accumulation of n-6 and n-3 PUFAs.
Further application of gene targeting in M. alpina strains should
facilitate improved PUFA productivity and help elucidate the
enzyme pathways of PUFA biosynthesis.
Conclusions and future perspectives
The present review summarizes studies on lipogenesis in
M. alpina 1S-4, the development of efficient gene manipulation sys-
tems for this strain, and the utilization of various M. alpina 1S-4
mutants for the production of beneficial PUFAs, especially ARA.
The M. alpina 1S-4 wild-type, derivative mutants, and transfor-
mants are potential sources of triacylglycerols containing various
Table 4
Polyunsaturated fatty acid (PUFA) production by mutants and transformants derived from M. alpina 1S-4.
Fatty acid Target genea Parentb Methodc Productivity
ARA D12 JT-180 OE Higher production (2.0 g/L/7 days, 39% of total fatty acids) than the M. alpina 1S-4 wild-
type (1.2 g/L/7 days, 21%)
malce1 1S-4 OE Higher ARA production (0.76 g/L/6 days, 34%) than the wild-type (0.68 g/L/6 days, 28%)
glelo 1S-4 OE Higher ARA production (3.6 g/L/10 days, 28%) than the wild-type (1.9 g/L/10 days, 19%)
PavD5 1S-4 OE Higher ARA composition (39%) and lower DGLA composition in the transformant than the
wild-type (19% and 4%, respectively)
OstD6 1S-4 OE Higher ARA composition (37%) in the transformant than the wild-type (19%)
TriD12 1S-4 OE Higher ARA composition (36%) in the transformant than the wild-type (19%)
18:1n-9 D6-1 JT-180 Ri 2.76 g/L/6 days, 68% of total fatty acid
EPA x3 1S-4 OE 0.68 g/L, 38.2% of total fatty acid
sdd17m ST1358 OE 1.8 g/L, 26.4% of total fatty acid
ETA sdd17m S14 OE 2.76 g/L/6 days, 68% of total fatty acid
DGLA D5 1S-4 GT Higher DGLA composition (40%) than the mutant S14 strain (27%), with no ARA
accumulation versus 0.2% in the mutant S14
MA D12 1S-4 GT Higher MA composition (8.4%) than the mutant JT-180 (4.5%), with no n-6 and n-3 PUFAs
a The genes, except for PavD5, OstD6, TriD12, and sdd17m, were derived from M. alpina 1S-4. DX, DX desaturase gene; PavD5, Pavlova salina D5 desaturase; OstD6,
Ostreococcus lucimarinus D6 desaturase; TriD12, Tribolium castaneum D12 desaturase; sdd17m, Saprolegnia diclina D17 desaturase.
b JT-180, D12 desaturase-defective mutant; ST1358, x3 desaturase-defective mutant; S14, D5 desaturase-defective mutant.
c OE, overexpression; Ri, RNAi; GT, targeted gene-disruption (gene-targeting).
H. Kikukawa et al. / Journal of Advanced Research 11 (2018) 15–22 19
PUFAs, including n-1, n-3, n-4, n-6, n-7, and n-9 PUFAs. By selective
breeding of M. alpina and its mutants, it is possible to regulate the
flow of both endogenous and exogenous fatty acids, thereby modi-
fying the fatty acid profile and enhancing the production of desired
(i.e., beneficial) PUFAs. Recent studies on M. alpina and its mutants
have focused on molecular engineering of genes involved in PUFA
biosynthesis and yielded strains with improved PUFA productivity.
The molecular breeding of mutants and transgenic strains may
make it possible to produce desired PUFAs efficiently. However,
more efficient expression systems for enzymes involved in lipid
synthesis, PUFA synthesis, and lipid conversion, as well as improved
gene-silencing and targeted gene-disruption systems are needed to
facilitate the breeding ofM. alpina strains for large-scale production
of functional lipids with industrial applications.
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